Listar por autor "Villalón, Ricardo"
Mostrando ítems 1-2 de 2
-
Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone
Murray, Nigel P.; Aedo, Socrates; Villalón, Ricardo; Albarran, Vidal; Orrego, Shenda [Univ Mayor, Fac Med, Chile]; Guzmán, Eghon [Univ Mayor, Fac Med, Chile] (Cancer Intellilgence, 2020-10)Introduction: Twenty-five percent of stage II colon cancer (CC) patients relapse within 5 years due to minimal residual disease (MRD) not eliminated by surgery. We hypothesise that subtypes of MRD, defined by circulating ... -
The association of the neutrophil-lymphocyte ratio with the presence of minimal residual disease and outcome in patients with Stage II colon cancer treated with surgery alone
Murray, Nigel P.; Villalón, Ricardo; Orrego, Shenda [Univ Mayor, Fac Med, Chile]; Guzmán, Eghon [Univ Mayor, Fac Med, Chile] (Wiley-Blackwell Publishing Ltd, 2021-04)Aim Despite curative surgery, 25% of patients with Stage II colorectal cancer will relapse due to minimal residual disease (MRD). Markers of immune function, such as the neutrophil to lymphocyte ratio (NLR), may be associated ...